Implications of Vascular Endothelial Growth Factor for Postischemic Neurovascular Remodeling

[1]  M. Chopp,et al.  Neurorestorative treatment of stroke: Cell and pharmacological approaches , 2006, NeuroRX.

[2]  G. Olmos,et al.  Vascular endothelial growth factor protects motoneurons from serum deprivation–induced cell death through phosphatidylinositol 3-kinase-mediated p38 mitogen-activated protein kinase inhibition , 2009, Neuroscience.

[3]  A. T. Argaw,et al.  VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown , 2009, Proceedings of the National Academy of Sciences.

[4]  C. Ali,et al.  Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic , 2009, Trends in Neurosciences.

[5]  K. Tanonaka,et al.  Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia. , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  Lars Jakobsson,et al.  Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. , 2008, Blood.

[7]  T. M. Hansen,et al.  Vascular endothelial growth factor and angiopoietins in neurovascular regeneration and protection following stroke. , 2008, Current neurovascular research.

[8]  R. Roskoski.  VEGF receptor protein-tyrosine kinases: structure and regulation. , 2008, Biochemical and biophysical research communications.

[9]  Jianhua Huang,et al.  A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation , 2008, Nature.

[10]  M. Chopp,et al.  Neural Progenitor Cells Treated with EPO Induce Angiogenesis through the Production of Vegf , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  Tamara Roitbak,et al.  Neural Stem/Progenitor Cells Promote Endothelial Cell Morphogenesis and Protect Endothelial Cells against Ischemia via HIF-1α-Regulated VEGF Signaling , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  E. Lo,et al.  A new penumbra: transitioning from injury into repair after stroke , 2008, Nature Medicine.

[13]  G. Olmos,et al.  Vascular endothelial growth factor protects spinal cord motoneurons against glutamate‐induced excitotoxicity via phosphatidylinositol 3‐kinase , 2008, Journal of neurochemistry.

[14]  Jacqueline Slinn,et al.  Sustained up-regulation of semaphorin 3A, Neuropilin1, and doublecortin expression in ischemic mouse brain during long-term recovery. , 2008, Biochemical and biophysical research communications.

[15]  M. Chopp,et al.  Plasticity and remodeling of brain , 2008, Journal of the Neurological Sciences.

[16]  W. Robberecht,et al.  Vascular endothelial growth factor counteracts the loss of phospho‐Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis , 2007, Neuropathology and applied neurobiology.

[17]  T. Byzova,et al.  Mechanisms of Integrin–Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis , 2007, Circulation research.

[18]  N. Ikeda,et al.  VASCULAR ENDOTHELIAL GROWTH FACTOR GENE‐TRANSFERRED BONE MARROW STROMAL CELLS ENGINEERED WITH A HERPES SIMPLEX VIRUS TYPE 1 VECTOR CAN IMPROVE NEUROLOGICAL DEFICITS AND REDUCE INFARCTION VOLUME IN RAT BRAIN ISCHEMIA , 2007, Neurosurgery.

[19]  J. LaManna,et al.  Physiologic angiodynamics in the brain. , 2007, Antioxidants & redox signaling.

[20]  Ling Wei,et al.  The Effect of Recombinant Human Erythropoietin on Neurovasculature Repair after Focal Ischemic Stroke in Neonatal Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.

[21]  J. Cha,et al.  Upregulation of Vascular Endothelial Growth Factor Receptors Flt-1 and Flk-1 Following Acute Spinal Cord Contusion in Rats , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  K. Preissner,et al.  Flt‐1, but not Flk‐1 mediates hyperpermeability through activation of the PI3‐K/Akt pathway , 2007, Journal of cellular physiology.

[23]  M. Chopp,et al.  Axonal sprouting into the denervated spinal cord and synaptic and postsynaptic protein expression in the spinal cord after transplantation of bone marrow stromal cell in stroke rats , 2007, Brain Research.

[24]  Ling Wei,et al.  Erythropoietin-Induced Neurovascular Protection, Angiogenesis, and Cerebral Blood Flow Restoration after Focal Ischemia in Mice , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  Shuzhen Guo,et al.  Cell–cell Signaling in the Neurovascular Unit , 2007, Neurochemical Research.

[26]  Armin Schneider,et al.  New targets for established proteins: exploring G-CSF for the treatment of stroke. , 2007, Trends in pharmacological sciences.

[27]  A. Kelly,et al.  Neurotrophins and their receptors: roles in plasticity, neurodegeneration and neuroprotection. , 2007, Biochemical Society transactions.

[28]  M. Chopp,et al.  Angiopoietin1/TIE2 and VEGF/FLK1 Induced by MSC Treatment Amplifies Angiogenesis and Vascular Stabilization after Stroke , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Y. Wang,et al.  Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving angiopoietin-1 signal way , 2007, Eye.

[30]  H. Augustin,et al.  Neuropilin‐1 and neuropilin‐2 enhance VEGF121 stimulated signal transduction by the VEGFR‐2 receptor , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  K. Jin,et al.  VEGF‐overexpressing transgenic mice show enhanced post‐ischemic neurogenesis and neuromigration , 2007, Journal of neuroscience research.

[32]  H. Weiss,et al.  Effects of anti-VEGF antibody on blood–brain barrier disruption in focal cerebral ischemia , 2007, Experimental Neurology.

[33]  M. Qiu,et al.  VEGF overexpression enhances striatal neurogenesis in brain of adult rat after a transient middle cerebral artery occlusion , 2007, Journal of neuroscience research.

[34]  Scott Barbay,et al.  VEGF Protein Associates to Neurons in Remote Regions following Cortical Infarct , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  S. Wiegand,et al.  Vascular growth factors in cerebral ischemia , 2001, Molecular Neurobiology.

[36]  E. Kılıç,et al.  Human vascular endothelial growth factor protects axotomized retinal ganglion cells in vivo by activating ERK-1/2 and Akt pathways , 2006 .

[37]  Yiqian Zhu,et al.  Adeno-Associated Viral Vector-Mediated Hypoxia-Inducible Vascular Endothelial Growth Factor Gene Expression Attenuates Ischemic Brain Injury After Focal Cerebral Ischemia in Mice , 2006, Stroke.

[38]  M. Hennerici,et al.  High-dose atorvastatin after stroke or transient ischemic attack. , 2006, The New England journal of medicine.

[39]  John H. Zhang,et al.  Inhibition of Integrin αvβ3 Ameliorates Focal Cerebral Ischemic Damage in the Rat Middle Cerebral Artery Occlusion Model , 2006 .

[40]  D. Stewart,et al.  Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment , 2006, Gene Therapy.

[41]  E. Kılıç,et al.  The phosphatidylinositol‐3 kinase/Akt pathway mediates VEGF's neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[42]  Y. Liu,et al.  Permeability of injured blood brain barrier for exogenous bFGF and protection mechanism of bFGF in rat brain ischemia , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[43]  YiLong Dong,et al.  Transmyocardial revascularization and vascular endothelial growth factor administration enhance effect of cell transplantation for myocardial infarct repair in rats , 2006, Coronary artery disease.

[44]  P. Lyden,et al.  Contraindications of VEGF-based therapeutic angiogenesis: effects on macrophage density and histology of normal and ischemic brains. , 2006, Vascular pharmacology.

[45]  L. Claesson‐Welsh,et al.  VEGF receptor signalling ? in control of vascular function , 2006, Nature Reviews Molecular Cell Biology.

[46]  J. Chilton.  Molecular mechanisms of axon guidance. , 2006, Developmental biology.

[47]  T. Dalkara,et al.  VEGF Protects Brain against Focal Ischemia without Increasing Blood–Brain Permeability when Administered Intracerebroventricularly , 2006 .

[48]  M. Shibuya.  Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. , 2006, Endothelium : journal of endothelial cell research.

[49]  M. Fernando,et al.  Expression of Vascular Endothelial Growth Factor and Its Receptors in the Central Nervous System in Amyotrophic Lateral Sclerosis , 2006, Journal of neuropathology and experimental neurology.

[50]  John H. Zhang,et al.  Inhibition of integrin alphavbeta3 ameliorates focal cerebral ischemic damage in the rat middle cerebral artery occlusion model. , 2006, Stroke.

[51]  E. Kılıç,et al.  Post-ischemic delivery of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor rosuvastatin protects against focal cerebral ischemia in mice via inhibition of extracellular-regulated kinase-1/-2 , 2005, Neuroscience.

[52]  K. Jin,et al.  From angiogenesis to neuropathology , 2005, Nature.

[53]  D. Hicklin,et al.  Granulocyte colony‐stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[54]  J. Roh,et al.  Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia , 2005, Neuroscience Research.

[55]  K. Suk,et al.  The function and integrity of the neurovascular unit rests upon the integration of the vascular and inflammatory cell systems. , 2005, Current neurovascular research.

[56]  Sheng-fu Li,et al.  Neuroprotective effect of exogenous vascular endothelial growth factor on rat spinal cord neurons in vitro hypoxia. , 2005, Chinese medical journal.

[57]  Tobias Steigleder,et al.  The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis. , 2005, The Journal of clinical investigation.

[58]  T. Abumiya,et al.  Aggravation of hemorrhagic transformation by early intraarterial infusion of low-dose vascular endothelial growth factor after transient focal cerebral ischemia in rats , 2005, Brain Research.

[59]  Yiqian Zhu,et al.  Angiopoietin-2 Facilitates Vascular Endothelial Growth Factor-Induced Angiogenesis in the Mature Mouse Brain , 2005, Stroke.

[60]  H. Nakase,et al.  Vascular Endothelial Growth Factor Antagonist Reduces Brain Edema Formation and Venous Infarction , 2005, Stroke.

[61]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[62]  H. Bøtker,et al.  Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial. , 2005, Journal of the American College of Cardiology.

[63]  A. Syvänen,et al.  Vascular endothelial growth factor gene expression in middle cerebral artery occlusion in the rat , 2005, Acta anaesthesiologica Scandinavica.

[64]  S. Finklestein,et al.  Growth factor treatment of stroke. , 2005, Current drug targets. CNS and neurological disorders.

[65]  P. Carmeliet,et al.  A Novel Role for Vascular Endothelial Growth Factor as an Autocrine Survival Factor for Embryonic Stem Cells during Hypoxia* , 2005, Journal of Biological Chemistry.

[66]  R. Gaiser,et al.  Circulating Angiogenic Factors and the Risk of Preeclampsia , 2005 .

[67]  M. Chopp,et al.  Atorvastatin Induction of VEGF and BDNF Promotes Brain Plasticity after Stroke in Mice , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[68]  D. Carbone,et al.  Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation1 , 2005, The Journal of Immunology.

[69]  Claudio L Bassetti,et al.  VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. , 2004, Brain : a journal of neurology.

[70]  矢野 昭正.  Encapsulated vascular endothelial growth factor-secreting cell grafts have neuroprotective and angiogenic effects on focal cerebral ischemia , 2005 .

[71]  J. Hubbell,et al.  Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating αvβ3-integrin and activating VEGF-R2 , 2004 .

[72]  S. Soker,et al.  Alterations in angiogenic growth factors and neuronal nitric oxide synthase expression in chronic cavernosal ischemia , 2004, International Journal of Impotence Research.

[73]  T. Asahara,et al.  Endothelial progenitor cells for postnatal vasculogenesis. , 2004, American journal of physiology. Cell physiology.

[74]  曲东锋.  Stroke Prevention by Aggressive Reduction in Cholesterol Levels , 2004 .

[75]  T. Acker,et al.  Direct Stimulation of Adult Neural Stem Cells In Vitro and Neurogenesis In Vivo by Vascular Endothelial Growth Factor , 2004, Brain pathology.

[76]  D. McCreery,et al.  Neuroprotection of Ischemic Brain by Vascular Endothelial Growth Factor is Critically Dependent on Proper Dosage and May Be Compromised by Angiogenesis , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[77]  Jeffrey M. Rosenstein,et al.  New roles for VEGF in nervous tissue—beyond blood vessels , 2004, Experimental Neurology.

[78]  Stefanie Dimmeler,et al.  Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. , 2004, Circulation.

[79]  J. Roh,et al.  VEGF protects human cerebral hybrid neurons from in vitro ischemia , 2004, Neuroreport.

[80]  K. Pumiglia,et al.  Vascular endothelial growth factor-mediated activation of p38 is dependent upon Src and RAFTK/Pyk2 , 2004, Oncogene.

[81]  J. Hubbell,et al.  Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2. , 2004, Microvascular research.

[82]  T. Yasuhara,et al.  The Potential Role of Vascular Endothelial Growth Factor in the Central Nervous System , 2004, Reviews in the neurosciences.

[83]  J. Rosenstein,et al.  Neurotrophic Effects of Vascular Endothelial Growth Factor on Organotypic Cortical Explants and Primary Cortical Neurons , 2003, The Journal of Neuroscience.

[84]  Kyu-Won Kim,et al.  Coordinated interaction of the vascular and nervous systems: from molecule- to cell-based approaches. , 2003, Biochemical and biophysical research communications.

[85]  Brian H Annex,et al.  Claudication of Vascular Endothelial Growth Factor 121 in Patients With Disabling Intermittent Disease : A Phase II Randomized , Double-Blind , Controlled Study of Adenoviral Delivery Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial , 2003 .

[86]  Lena Claesson-Welsh,et al.  Ligand-induced Vascular Endothelial Growth Factor Receptor-3 (VEGFR-3) Heterodimerization with VEGFR-2 in Primary Lymphatic Endothelial Cells Regulates Tyrosine Phosphorylation Sites* , 2003, Journal of Biological Chemistry.

[87]  F. Gao,et al.  Vascular Endothelial Growth Factor Expression and Angiogenesis Induced by Chronic Cerebral Hypoperfusion in Rat Brain , 2003, Neurosurgery.

[88]  Peter Carmeliet,et al.  Blood vessels and nerves: common signals, pathways and diseases , 2003, Nature Reviews Genetics.

[89]  M. Giacca,et al.  Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil. , 2003, Pharmacological research.

[90]  M. Hennerici,et al.  Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study , 2003, Cerebrovascular Diseases.

[91]  R. Gay,et al.  Angiogenic and angiostatic factors in the molecular control of angiogenesis. , 2003, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[92]  G. D. del Zoppo,et al.  Cerebral Microvessel Responses to Focal Ischemia , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[93]  D. Marchionini,et al.  Angiogenic and neurotrophic effects of vascular endothelial growth factor (VEGF165): studies of grafted and cultured embryonic ventral mesencephalic cells , 2003, Experimental Neurology.

[94]  Christoph Dehio,et al.  Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1 , 2003, Nature Medicine.

[95]  K. Jin,et al.  VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. , 2003, The Journal of clinical investigation.

[96]  J. Hartikainen,et al.  Safety and Feasibility of Catheter-Based Local Intracoronary Vascular Endothelial Growth Factor Gene Transfer in the Prevention of Postangioplasty and In-Stent Restenosis and in the Treatment of Chronic Myocardial Ischemia: Phase II Results of the Kuopio Angiogenesis Trial (KAT) , 2003, Circulation.

[97]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[98]  N. Suttorp,et al.  p38 MAP Kinase—a molecular switch between VEGF‐induced angiogenesis and vascular hyperpermeability , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[99]  M. Schwab,et al.  Anti—Nogo-A Antibody Infusion 24 Hours after Experimental Stroke Improved Behavioral Outcome and Corticospinal Plasticity in Normotensive and Spontaneously Hypertensive Rats , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[100]  D. Kim,et al.  Angiogenic Gene Therapy in Patients with Ischemic Cardiovascular Diseases , 2003 .

[101]  S. Sullivan,et al.  Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume , 2003, Acta Neurochirurgica.

[102]  Holger Gerhardt,et al.  Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. , 2002, Genes & development.

[103]  V. Arolt,et al.  Vascular Endothelial Growth Factor Protects Cultured Rat Hippocampal Neurons against Hypoxic Injury via an Antiexcitotoxic, Caspase-Independent Mechanism , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[104]  P. Lewczuk,et al.  Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial , 2002, Molecular medicine.

[105]  J. Dichgans,et al.  Neuroprotection by Hypoxic Preconditioning Requires Sequential Activation of Vascular Endothelial Growth Factor Receptor and Akt , 2002, The Journal of Neuroscience.

[106]  S. Ylä-Herttuala,et al.  Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[107]  P. Carmeliet,et al.  Cell Type‐Specific Expression of Neuropilins in an MCA‐Occlusion Model in Mice Suggests a Potential Role in Post‐Ischemic Brain Remodeling , 2002, Journal of neuropathology and experimental neurology.

[108]  M. Chopp,et al.  Vascular endothelial growth factor and angiopoietins in focal cerebral ischemia. , 2002, Trends in cardiovascular medicine.

[109]  M. Tessier-Lavigne,et al.  Neuropilins as Semaphorin Receptors , 2002 .

[110]  G. Neufeld,et al.  The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. , 2002, Advances in experimental medicine and biology.

[111]  M. Tessier-Lavigne,et al.  Neuropilins as Semaphorin receptors: in vivo functions in neuronal cell migration and axon guidance. , 2002, Advances in experimental medicine and biology.

[112]  M. Karkkainen,et al.  Lymphatic endothelium: a new frontier of metastasis research , 2002, Nature Cell Biology.

[113]  Lena Claesson-Welsh,et al.  VEGF Receptor Signal Transduction , 2001, Science's STKE.

[114]  K. Jin,et al.  Caspase-3 and the regulation of hypoxic neuronal death by vascular endothelial growth factor , 2001, Neuroscience.

[115]  J. Mestan,et al.  Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro. , 2001, The Journal of pharmacology and experimental therapeutics.

[116]  Paul J. McMillan,et al.  Angiogenesis after Stroke is Correlated with Increased Numbers of Macrophages: The Clean-up Hypothesis , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[117]  G. D. del Zoppo,et al.  Rapid Loss of Microvascular Integrin Expression during Focal Brain Ischemia Reflects Neuron Injury , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[118]  W. Lin,et al.  Induction of Tie-1 and Tie-2 Receptor Protein Expression after Cerebral Ischemia—Reperfusion , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[119]  J. Bolz,et al.  Semaphorin 3A–Vascular Endothelial Growth Factor-165 Balance Mediates Migration and Apoptosis of Neural Progenitor Cells by the Recruitment of Shared Receptor , 2001, The Journal of Neuroscience.

[120]  M. Vitek,et al.  Vascular endothelial growth factor rescues hippocampal neurons from glutamate‐induced toxicity: signal transduction cascades , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[121]  M. Chopp,et al.  Up-Regulation of Neuropilin-1 in Neovasculature after Focal Cerebral Ischemia in the Adult Rat , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[122]  K. Alitalo,et al.  Tie receptors: new modulators of angiogenic and lymphangiogenic responses , 2001, Nature Reviews Molecular Cell Biology.

[123]  M. Persico.  Placenta Growth Factor , 2001 .

[124]  J. Seylaz,et al.  Dynamic Cerebral Microcirculatory Changes in Transient Forebrain Ischemia in Rats: Involvement of Type I Nitric Oxide Synthase , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[125]  M Chopp,et al.  VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. , 2000, The Journal of clinical investigation.

[126]  G. Semenza,et al.  Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity* , 2000, The Journal of Biological Chemistry.

[127]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[128]  K. Jin,et al.  Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[129]  Z. Radisavljevic,et al.  Vascular Endothelial Growth Factor Up-regulates ICAM-1 Expression via the Phosphatidylinositol 3 OH-kinase/AKT/Nitric Oxide Pathway and Modulates Migration of Brain Microvascular Endothelial Cells* , 2000, The Journal of Biological Chemistry.

[130]  R. Klein,et al.  Eph receptors and ephrin ligands. essential mediators of vascular development. , 2000, Trends in cardiovascular medicine.

[131]  M. Bernaudin,et al.  Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. , 2000, The American journal of pathology.

[132]  M. Nugent,et al.  Fibroblast growth factor-2. , 2000, The international journal of biochemistry & cell biology.

[133]  Teng-Nan Lin,et al.  Induction of Angiopoietin and Tie Receptor mRNA Expression after Cerebral Ischemia–Reperfusion , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[134]  R. Jain,et al.  Leaky vessels? Call Ang1! , 2000, Nature Medicine.

[135]  R. Hendel,et al.  Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect. , 2000, Circulation.

[136]  P. Carmeliet.  Gene targeting and gene transfer to unravel the molecular basis of the formation and disorders of blood vessels. , 2000, Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie.

[137]  J. Thiery,et al.  Fibroblast growth factor-2. , 2000, The international journal of biochemistry & cell biology.

[138]  Thomas N. Sato,et al.  Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. , 1999, Science.

[139]  M. Nomura,et al.  Placenta Growth Factor and Vascular Endothelial Growth Factor B and C Expression in Microvascular Endothelial Cells and Pericytes , 1999, The Journal of Biological Chemistry.

[140]  N. van Bruggen,et al.  VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. , 1999, The Journal of clinical investigation.

[141]  J. Koziol,et al.  Activated Microvessels Express Vascular Endothelial Growth Factor and Integrin αvβ3 During Focal Cerebral Ischemia , 1999 .

[142]  J. Borredon,et al.  Dynamic In Vivo Measurement of Erythrocyte Velocity and Flow in Capillaries and of Microvessel Diameter in the Rat Brain by Confocal Laser Microscopy , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[143]  S. Soker,et al.  Neuropilin-1 Mediates Collapsin-1/Semaphorin III Inhibition of Endothelial Cell Motility , 1999, The Journal of cell biology.

[144]  K. Plate,et al.  Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct. , 1999, Journal of neuropathology and experimental neurology.

[145]  Wei Li,et al.  VEGF prevents apoptosis of human microvascular endothelial cells via opposing effects on MAPK/ERK and SAPK/JNK signaling. , 1999, Experimental cell research.

[146]  J. Koziol,et al.  Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia. , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[147]  W. Risau,et al.  Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[148]  Vishva Dixit,et al.  Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway , 1998, The Journal of Biological Chemistry.

[149]  Y. Olsson,et al.  Expression of Vascular Endothelial Growth Factor (VEGF) and its Receptors (Flt-1 and Flk-1) following Permanent and Transient Occlusion of the Middle Cerebral Artery in the Rat , 1998, Journal of neuropathology and experimental neurology.

[150]  Yasuto Itoyama,et al.  Reduction of Ischemic Damage by Application of Vascular Endothelial Growth Factor in Rat Brain after Transient Ischemia , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[151]  Daniel B. Rifkin,et al.  Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis , 1998, The Journal of cell biology.

[152]  S. Mandriota,et al.  Regulation of vascular endothelial growth factor receptor-2 (Flk-1) expression in vascular endothelial cells. , 1998, Experimental cell research.

[153]  Shay Soker,et al.  Neuropilin-1 Is Expressed by Endothelial and Tumor Cells as an Isoform-Specific Receptor for Vascular Endothelial Growth Factor , 1998, Cell.

[154]  M. Tessier-Lavigne,et al.  Neuropilin Is a Receptor for the Axonal Chemorepellent Semaphorin III , 1997, Cell.

[155]  Douglas Hanahan,et al.  Signaling Vascular Morphogenesis and Maintenance , 1997, Science.

[156]  H. Granger,et al.  VEGF induces NO-dependent hyperpermeability in coronary venules. , 1996, The American journal of physiology.

[157]  G. Semenza,et al.  Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 , 1996, Molecular and cellular biology.

[158]  Takayuki Asahara,et al.  Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.

[159]  J. Koziol,et al.  Integrin alphavbeta3 is expressed in selected microvessels after focal cerebral ischemia. , 1996, The American journal of pathology.

[160]  Shay Soker,et al.  Characterization of Novel Vascular Endothelial Growth Factor (VEGF) Receptors on Tumor Cells That Bind VEGF via Its Exon 7-encoded Domain (*) , 1996, The Journal of Biological Chemistry.

[161]  Janet Rossant,et al.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice , 1995, Nature.

[162]  J. Rossant,et al.  Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium , 1995, Nature.

[163]  J. Winer,et al.  Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. , 1994, The Journal of biological chemistry.

[164]  Atsushi Namiki,et al.  Indirect Angiogenic Cytokines Upregulate VEGF and bFGF Gene Expression in Vascular Smooth Muscle Cells, Whereas Hypoxia Upregulates VEGF Expression Only , 1994 .

[165]  J. Park,et al.  The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. , 1993, Molecular biology of the cell.

[166]  M. Schwartz,et al.  Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms , 1993, The Journal of cell biology.

[167]  E. Oldfield,et al.  Expression of vascular permeability factor/vascular endothelial growth factor in normal rat tissues. , 1993, The American journal of physiology.

[168]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[169]  J. Winer,et al.  Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. , 1992, The Journal of biological chemistry.

[170]  R. Eddy,et al.  Identification of a new endothelial cell growth factor receptor tyrosine kinase. , 1991, Oncogene.

[171]  M. Shibuya,et al.  Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. , 1990, Oncogene.